Aerie Pharmaceuticals Announces Appointment of Isabel Moredo, PharmD, as Eastern Regional Director of Medical Science Liaisons

IRVINE, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of glaucoma and other diseases of the eye, today announced the appointment of Isabel Moredo, PharmD, as Eastern Regional Director of Medical Science Liaisons, reporting to Welyn Bui, PharmD, Aerie’s National Director of Medical Affairs. Dr. Moredo will be responsible for leadi

Full Story →